Shenzhen SiBiono GeneTech Co.,Ltd

Quick facts

Marketed products

• chemotherapy plus p53 · Oncology
  This combination therapy uses chemotherapy alongside a p53 gene therapy to restore tumor suppressor function and enhance cancer cell death.
• p53 gene therapy · Oncology
  This gene therapy delivers functional p53 tumor suppressor gene into cancer cells to restore apoptosis and cell cycle arrest.
• p53 gene with surgery · Oncology
  A p53 gene therapy that restores wild-type p53 tumor suppressor function in cancer cells, typically administered intratumorally in combination with surgical resection.
• p53 with chemotherapy · Oncology
  A gene therapy that delivers functional p53 tumor suppressor gene to cancer cells to restore apoptosis and cell cycle arrest, used in combination with chemotherapy.
• rAd-p53 gene · Oncology
  rAd-p53 is a recombinant adenovirus carrying the wild-type p53 tumor suppressor gene that restores p53 function in cancer cells to induce apoptosis and inhibit tumor growth.

Phase 2 pipeline

• p53 gene
• rAd-p53
• rAdp53
• rAdp53 plus cisplatin
• TAE plus P53 gene
• Trans-catheter embolization

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Shenzhen SiBiono GeneTech Co.,Ltd portfolio CI brief
• Shenzhen SiBiono GeneTech Co.,Ltd pipeline updates RSS